Table 1 Characteristics of study participants by disease status

Vision

^aBetter-eye VA logMAR, median (IQR)

0.08 (0.00, 0.16)

0.16 (0.08, 0.34)

0.38 (0.20, 0.64)

^aBinocular log CS, median (IQR)

1.85 (1.80, 1.98)

1.50 (1.35, 1.75)

1.50 (1.35, 1.60)

^aBetter-eye VF MD, median (IQR)

0.17 (0.90, -0.65)

−7.96 (-4.81, -16.46)

--

^bNo. with cataract/PCO either eye, N (%)

12 (21.8)

31 (37.4)

18 (33.3)

^bNo. with cataract/PCO both eyes, N (%)

6 (10.7)

12 (14.5)

8 (14.8)

Demographics

^aAge in years, median (IQR)

69.4 (65.2, 72.8)

70.4 (66.4, 74.5)

75.8 (71.0, 78.3)

^bEthnicity, N (%)

White non-Hispanic

45 (75.0)

46 (55.4)

57 (90.5)

White-Hispanic

1 (1.7)

6 (7.2)

4 (6.4)

African-American

12 (20.0)

27 (32.5)

1 (1.6)

Asian

2 (3.3)

4 (4.8)

1 (1.6)

^bFemale, N (%)

37 (61.7)

44 (53.0)

36 (57.1)

^aEducation in years, median (IQR)

16.5 (14.0, 17.0)

16.0 (14.0, 17.0)

16 (13.0, 17.0)

^bEmployed, N (%)

23 (38.3)

35 (42.2)

14 (22.2)

^bLiving alone, N (%)

11 (18.3)

16 (19.3)

14 (22.2)

Health/cognition

^aBody mass index in kg/m², median (IQR)

27.9 (23.8, 32.2)

28.0 (24.5, 32.2)

27.5 (24.6, 32.5)

^aGrip strength in kg, median (IQR)

26.3 (21.3, 32.3)

28.7 (21.2, 36.7)

27.0 (21.3, 34.3)

^aNo. comorbid illnesses, N (IQR)

2 (1, 3)

2 (1, 3)

2 (1, 4)

^bNo. depressive symptoms, N (%)

3 (5.0)

5 (6.0)

3 (4.8)

^aMMSE-VI score as #/22, N(IQR)

21 (20, 22)

21 (20, 22)

21 (20, 22)